Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric maltol capsules for iron deficiency anemia in adults with inflammatory bowel disease
CTR20262668Phase 3Active
- Sponsor
- Qianyuan Baoling Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Qianyuan Baoling Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on CTR20262668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262668.